vs
Side-by-side financial comparison of LANDSTAR SYSTEM INC (LSTR) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
LANDSTAR SYSTEM INC is the larger business by last-quarter revenue ($1.2B vs $622.0M, roughly 1.9× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 3.4%, a 31.1% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 1.6%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -2.2%).
Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
LSTR vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $622.0M |
| Net Profit | $39.4M | $214.2M |
| Gross Margin | 9.6% | — |
| Operating Margin | 4.5% | 62.4% |
| Net Margin | 3.4% | 34.4% |
| Revenue YoY | 1.6% | 4.8% |
| Net Profit YoY | 32.3% | 2.9% |
| EPS (diluted) | $1.16 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M |
| Q1 26 | $39.4M | — | ||
| Q4 25 | $23.9M | $214.2M | ||
| Q3 25 | $19.4M | $288.2M | ||
| Q2 25 | $41.9M | $30.2M | ||
| Q1 25 | $29.8M | $238.3M | ||
| Q4 24 | $46.2M | $208.2M | ||
| Q3 24 | $50.0M | $544.0M | ||
| Q2 24 | $52.6M | $102.0M |
| Q1 26 | 9.6% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 4.5% | — | ||
| Q4 25 | 2.5% | 62.4% | ||
| Q3 25 | 2.2% | 70.1% | ||
| Q2 25 | 4.6% | 36.3% | ||
| Q1 25 | 3.4% | 94.0% | ||
| Q4 24 | 4.8% | 60.9% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 5.6% | 50.2% |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 2.0% | 34.4% | ||
| Q3 25 | 1.6% | 47.3% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 2.6% | 41.9% | ||
| Q4 24 | 3.8% | 35.1% | ||
| Q3 24 | 4.1% | 96.3% | ||
| Q2 24 | 4.3% | 19.0% |
| Q1 26 | $1.16 | — | ||
| Q4 25 | $0.70 | $0.49 | ||
| Q3 25 | $0.56 | $0.67 | ||
| Q2 25 | $1.20 | $0.07 | ||
| Q1 25 | $0.85 | $0.55 | ||
| Q4 24 | $1.30 | $0.46 | ||
| Q3 24 | $1.41 | $1.21 | ||
| Q2 24 | $1.48 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $411.0M | $618.7M |
| Total DebtLower is stronger | $26.1M | $9.0B |
| Stockholders' EquityBook value | $799.0M | $9.7B |
| Total Assets | $1.6B | $19.6B |
| Debt / EquityLower = less leverage | 0.03× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $411.0M | — | ||
| Q4 25 | $452.2M | $618.7M | ||
| Q3 25 | $434.4M | $938.9M | ||
| Q2 25 | $426.2M | $631.9M | ||
| Q1 25 | $473.4M | $1.1B | ||
| Q4 24 | $566.6M | $929.0M | ||
| Q3 24 | $531.3M | $950.1M | ||
| Q2 24 | $504.0M | $1.8B |
| Q1 26 | $26.1M | — | ||
| Q4 25 | $0 | $9.0B | ||
| Q3 25 | $0 | $8.9B | ||
| Q2 25 | $0 | $8.0B | ||
| Q1 25 | $0 | $7.6B | ||
| Q4 24 | $0 | $7.6B | ||
| Q3 24 | $0 | $7.6B | ||
| Q2 24 | $0 | $7.6B |
| Q1 26 | $799.0M | — | ||
| Q4 25 | $795.7M | $9.7B | ||
| Q3 25 | $888.7M | $9.6B | ||
| Q2 25 | $921.8M | $9.5B | ||
| Q1 25 | $930.8M | $9.8B | ||
| Q4 24 | $972.4M | $10.3B | ||
| Q3 24 | $1.0B | $10.3B | ||
| Q2 24 | $1.0B | $9.8B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.7B | $19.3B | ||
| Q2 25 | $1.7B | $18.3B | ||
| Q1 25 | $1.7B | $17.6B | ||
| Q4 24 | $1.8B | $18.2B | ||
| Q3 24 | $1.8B | $18.0B | ||
| Q2 24 | $1.8B | $17.7B |
| Q1 26 | 0.03× | — | ||
| Q4 25 | 0.00× | 0.92× | ||
| Q3 25 | 0.00× | 0.93× | ||
| Q2 25 | 0.00× | 0.84× | ||
| Q1 25 | 0.00× | 0.78× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.00× | 0.74× | ||
| Q2 24 | 0.00× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $72.7M | $827.1M | ||
| Q3 25 | $89.3M | $702.6M | ||
| Q2 25 | $7.1M | $364.0M | ||
| Q1 25 | $55.7M | $596.1M | ||
| Q4 24 | $61.1M | $742.5M | ||
| Q3 24 | $83.1M | $703.6M | ||
| Q2 24 | $48.1M | $658.2M |
| Q1 26 | — | — | ||
| Q4 25 | $70.5M | — | ||
| Q3 25 | $86.0M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $53.8M | — | ||
| Q4 24 | $54.4M | — | ||
| Q3 24 | $75.6M | — | ||
| Q2 24 | $40.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 3.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.04× | 3.86× | ||
| Q3 25 | 4.61× | 2.44× | ||
| Q2 25 | 0.17× | 12.06× | ||
| Q1 25 | 1.87× | 2.50× | ||
| Q4 24 | 1.32× | 3.57× | ||
| Q3 24 | 1.66× | 1.29× | ||
| Q2 24 | 0.91× | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSTR
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
